Compare ABCL & NTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | NTCT |
|---|---|---|
| Founded | 2012 | 1984 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 2.9B |
| IPO Year | 2020 | 1999 |
| Metric | ABCL | NTCT |
|---|---|---|
| Price | $11.22 | $37.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $8.40 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 9.1M | 573.9K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.91 | ★ 125.39 |
| EPS | N/A | ★ 0.29 |
| Revenue | $75,128,000.00 | ★ $891,820,000.00 |
| Revenue This Year | N/A | $6.02 |
| Revenue Next Year | $21.85 | $2.55 |
| P/E Ratio | ★ N/A | $133.90 |
| Revenue Growth | ★ 160.56 | N/A |
| 52 Week Low | $2.75 | $24.37 |
| 52 Week High | $12.58 | $45.28 |
| Indicator | ABCL | NTCT |
|---|---|---|
| Relative Strength Index (RSI) | 60.19 | 40.98 |
| Support Level | $10.44 | $37.09 |
| Resistance Level | N/A | $42.57 |
| Average True Range (ATR) | 0.78 | 0.90 |
| MACD | -0.08 | 0.04 |
| Stochastic Oscillator | 42.16 | 17.98 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
NetScout Systems Inc is engaged in providing enterprise network observability, carrier service assurance, cybersecurity, and Distributed Denial-of-Service (DDoS), protection solutions. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.